Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
66,8
Time (Latest trade)

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Florence Vicaire
  • Fredrik Juserius

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 13,84 13,84 2022-09-28
Nordnet Pensionsförsäkring 12,25 12,25 2022-09-28
Anders Ericsson 6,18 6,18 2022-05-17
Jan-Willem De Gier 5,16 5,16 2022-09-28
Joen Luirink 5,04 5,04 2022-09-28
Magnus Linderoth 3,84 3,84 2022-09-28
Johan Källstrand 3,28 3,28 2022-09-28
Anders Wall Stiftelser 2,77 2,77 2022-09-28
Maria Alrikson 2,24 2,24 2022-09-28
Peter Nilsson 2,04 2,04 2022-09-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-02-23 Bokslutskommuniké 2022